Benny C Askew

Title: Benny C. Askew: Innovator in Integrin Receptor Antagonists

Introduction

Benny C. Askew is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of integrin receptor antagonists. His work focuses on inhibiting the binding of fibrinogen to blood platelets, which is crucial for preventing unwanted platelet aggregation.

Latest Patents

Benny C. Askew holds a patent for integrin receptor antagonists, specifically fibrinogen receptor antagonists. This patent is particularly important as it provides a formula that can be utilized to inhibit the binding of fibrinogen to blood platelets. The implications of this invention are significant in the medical field, especially for conditions related to blood clotting.

Career Highlights

Benny C. Askew is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to further his research and development efforts in the pharmaceutical industry. His innovative work has the potential to impact various therapeutic areas, particularly in cardiovascular health.

Collaborations

Some of Benny C. Askew's notable coworkers include Mark E. Duggan and George D. Hartman. Their collaboration in research and development has contributed to advancements in the field of integrin receptor antagonists.

Conclusion

Benny C. Askew's contributions to the field of biochemistry and his innovative patent for integrin receptor antagonists highlight his importance as an inventor. His work at Merck & Co., Inc. continues to pave the way for advancements in medical treatments.